Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells

British Journal of Cancer

Volumn 86, Issue 7, 2002, Pages 1130-1135

  Schwarz, V A ^a   Hornung, R ^a   Fedier, A ^a   Fehr, M K ^a   Walt, H ^a   Haller, U ^a   Fink, Daniel ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

DNA mismatch repair; Drug resistance; m THPC; Photodynamic therapy

Indexed keywords

DNA; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; LASER MICROSCOPY; MISMATCH REPAIR; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0037041629     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600218     Document Type: Article

References (31)

1. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells
2. Loss of DNA mismatch repair in acquired resistance to cisplatin
3. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines
4. hMLH1 expression and cellular responses of ovarian tumor cells to treatment with cytotoxic anticancer agents
5. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors
6. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light
7. Mutagenicity of photodynamic therapy as compared to UVC and ionizing radiation in human and murine lymphoblast cell lines
8. Resistance to topoisomerase poisons due to loss of DNA mismatch repair
9. The role of DNA mismatch repair in platinum drug resistance
10. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin
11. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells
12. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts
13. 6-alkylguanine-DNA alkyltransferase analysis and response to temodal in newly diagnosed malignant glioma
14. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation
15. How does photodynamic therapy work?
16. In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79)
17. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro
18. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation
19. Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells
20. Reduced MLH1 expression in breast tumors after primary chemotherapy predicts disease-free survival
21. A comet assay of DNA damage and repair in K562 cells after photodynamic therapy using haematoporphyrin derivative, methylene blue and meso-tetrahydroxyphenylchlorin
22. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen
23. Yearly review; Photochemotherapy of cancer: Experimental research
24. Strand-specific mismatch repair in mammalian cells
25. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors
26. The photobiology of photodynamic therapy: Cellular targets and mechanisms
27. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy
28. Mitochondrial alterations in photodynamic therapy-resistant cells
29. In vitro induction of PDT resistance in HT29, HT1376 and SK-N-MC cells by various photosensitizers
30. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6
31. Hypermutability to ionizing radiation in mismatch repair-deficient Pms2 knockout mice